Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history. [electronic resource]
Producer: 20150205Description: 751-8 p. digitalISSN:- 1532-866X
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Azathioprine -- therapeutic use
- Comorbidity
- Female
- Glatiramer Acetate
- Greece -- epidemiology
- Humans
- Hydroxychloroquine -- therapeutic use
- Immunologic Factors -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Interferon-beta -- therapeutic use
- Lupus Erythematosus, Systemic -- drug therapy
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Multiple Sclerosis -- drug therapy
- Natalizumab
- Peptides -- therapeutic use
- Prevalence
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.